Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 341, pseudogene (RNU6-341P)
- Target
- RNU6-341P
- Molecular classification
- Other (pseudogene, small nuclear RNA family; not a receptor, enzyme, transporter, etc.)
01
Overview
RNU6-341P is a human pseudogene from the U6 small nuclear RNA family. U6 snRNA is a critical component of the spliceosome, the large RNA-protein complex responsible for excising introns from pre-mRNA during post-transcriptional processing in eukaryotes. The sequence of U6 snRNA is highly conserved, and functional U6 snRNA is essential for splicing and viability. Pseudogenes such as RNU6-341P are non-coding DNA segments thought to arise via gene duplication or retrotransposition during genome evolution and generally do not have a known biological function or clinical relevance. While the study of pseudogenes can provide insight into genome evolution or possible regulatory roles, RNU6-341P itself has no established role as a therapeutic target, biomarker, or disease gene.
- Other names
- RNU6-341PU6-341PU6 snRNA pseudogeneU6 small nuclear RNA pseudogene
02
Mechanism of action
None (as no drugs known to target the pseudogene, and it does not encode a protein target)
03
Biological functions
None (as a pseudogene, RNU6-341P does not have an established biological function; for canonical U6 snRNA, "splicing," specifically catalyzing intron excision from pre-mRNA)
04
Disease associations
None (no established role for pseudogenes like RNU6-341P in disease; canonical U6 snRNA function is essential for viability, but not a disease target itself)
Beyond the preview
Go deeper on RNA, U6 small nuclear 341, pseudogene (RNU6-341P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 341, pseudogene (RNU6-341P).